Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T.
Saved in:
| Title: | Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T. |
|---|---|
| Authors: | Dorff T; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California, USA., Hirasawa Y; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Acoba J; University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Pagano I; University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Tamura D; University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Pal S; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California, USA., Zhang M; Serimmune, Goleta, California, USA., Waitz R; Serimmune, Goleta, California, USA., Dhal A; Serimmune, Goleta, California, USA., Haynes W; Serimmune, Goleta, California, USA., Shon J; Serimmune, Goleta, California, USA., Scholz M; Prostate Oncology Specialists, Marina del Rey, California, USA., Furuya H; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Chan OTM; University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Huang J; University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Rosser C; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA charles.rosser@cshs.org. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Aug; Vol. 9 (8). |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
